v3.26.1
COLLABORATION AND RESEARCH AGREEMENTS (Detail Textuals) - USD ($)
$ / shares in Units, $ in Thousands
 12 Months Ended
Mar. 16, 2025
Dec. 31, 2025
Dec. 31, 2024
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Revenue   $ 42 $ 181
Other payables   367 0
Operating Expenses   11,529 $ 9,594
2025 Collaboration Agreement with OPKO [Member]      
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]      
Number of ordinary shares issued 3,685,226    
Purchase price of ordinary shares $ 8,000    
Purchase price per share $ 2.17    
Escrow agent, deposits $ 8,000    
Share issuance costs 75    
Other payables 515    
Other long-term liabilities $ 295    
Operating Expenses   $ 437  
Collaboration agreement, profit sharing and opt-out terms Under the terms of the 2025 Collaboration Agreement, the Company and OPKO will retain 40% and 60%, respectively, of all proceeds deriving from the Program, and will be responsible for 40% and 60% of the Program’s development costs, respectively. Following the completion of the Phase 1 stage, the Company may continue to fund its 40% share of the Program to maintain its right to proceeds or to opt-out (the “Opt-Out”). If the Company exercises the Opt-Out, then the Company and OPKO will retain 15% and 85%, respectively, of all proceeds deriving from the Program, while OPKO will be solely responsible for ongoing development and commercialization funding of the Program.